168 related articles for article (PubMed ID: 38313803)
21. Late Epstein-Barr virus-related post-transplant lymphoproliferative disorder with intestinal involvement in patient with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hjellbakk HK; Adamska MM; MaŁecki B; BrzeŹniakiewicz-Janus K; Łojko-Dankowska A; Gil L
Cent Eur J Immunol; 2020; 45(2):233-236. PubMed ID: 33456337
[TBL] [Abstract][Full Text] [Related]
22. Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.
Morscio J; Finalet Ferreiro J; Vander Borght S; Bittoun E; Gheysens O; Dierickx D; Verhoef G; Wlodarska I; Tousseyn T
Mod Pathol; 2017 Mar; 30(3):370-381. PubMed ID: 28059091
[TBL] [Abstract][Full Text] [Related]
23. A rare case of post-transplant lymphoproliferative disorder (Hodgkins lymphoma) post autologous stem cell transplantation: A case report and review of literature.
Khalid SN; Amir NZ; Khan ZA; Khan AM; Khalid RN; Ali MH; Ur-Rehman I; Abbasher Hussien Mohamed Ahmed K; Ullah I
Ann Med Surg (Lond); 2022 Oct; 82():104738. PubMed ID: 36268392
[TBL] [Abstract][Full Text] [Related]
24. Primary large B-cell lymphoma involving the cerebellopontine angle mimic acoustic schwannoma: Role of MR Spectroscopy in differential diagnosis. A case report.
Arcuri PP; Aiello V; Antonelli S; Cascini GL; Rossi M; Laganà D
Radiol Case Rep; 2023 Oct; 18(10):3729-3734. PubMed ID: 37636538
[TBL] [Abstract][Full Text] [Related]
25. Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder.
Kassa C; Reményi P; Sinkó J; Kállay K; Kertész G; Kriván G
Pediatr Transplant; 2018 Dec; 22(8):e13302. PubMed ID: 30345623
[TBL] [Abstract][Full Text] [Related]
26. A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia.
Zhu H; Li Q; Liu Y; Feng X; Deng Q
Cell Transplant; 2022; 31():9636897221117532. PubMed ID: 35979928
[TBL] [Abstract][Full Text] [Related]
27. High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.
Itonaga H; Kato T; Fujioka M; Taguchi M; Taniguchi H; Imaizumi Y; Yoshida S; Miyoshi H; Moriuchi Y; Ohshima K; Miyazaki Y
Intern Med; 2017; 56(14):1873-1877. PubMed ID: 28717085
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.
Mahapatra S; Chin CC; Iagaru A; Heerema-McKenney A; Twist CJ
Pediatr Blood Cancer; 2014 Nov; 61(11):2107-9. PubMed ID: 25066638
[TBL] [Abstract][Full Text] [Related]
29. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated posttransplant lymphoproliferative disorder involving the central nervous system following autologous hematopoietic stem cell transplantation for neuroblastoma.
Sano H; Fujimoto M; Okuno K; Ueyama J; Takano S; Hayashi K; Kanzaki S
Springerplus; 2014; 3():582. PubMed ID: 25332882
[TBL] [Abstract][Full Text] [Related]
31. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Kuno M; Ito A; Maeshima AM; Taniguchi H; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Int J Hematol; 2020 Aug; 112(2):193-199. PubMed ID: 32472530
[TBL] [Abstract][Full Text] [Related]
32. Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.
Chen DB; Liu XY; Kong FZ; Jiang Q; Shen DH
J Clin Pathol; 2021 Nov; 74(11):697-703. PubMed ID: 34011618
[TBL] [Abstract][Full Text] [Related]
33. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
34. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.
Fujimoto A; Hiramoto N; Yamasaki S; Inamoto Y; Ogata M; Sugio Y; Fukuda T; Uchida N; Ikegame K; Matsuoka KI; Shiratori S; Kondo T; Miyamoto T; Eto T; Ichinohe T; Kanda Y; Atsuta Y; Suzuki R;
Hematol Oncol; 2020 Apr; 38(2):146-152. PubMed ID: 31953867
[TBL] [Abstract][Full Text] [Related]
35. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
[TBL] [Abstract][Full Text] [Related]
36. Post-transplant lymphoproliferative disorder and management of residual mass post chemotherapy: Case report.
Schultz TD; Zepeda N; Moore RB
Int J Surg Case Rep; 2017; 38():115-118. PubMed ID: 28756359
[TBL] [Abstract][Full Text] [Related]
37. Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment.
Chiereghin A; Bertuzzi C; Piccirilli G; Gabrielli L; Squarzoni D; Turello G; Ferioli M; Sessa M; Bonifazi F; Zanoni L; Sabattini E; Lazzarotto T
Transpl Immunol; 2016 Feb; 34():60-4. PubMed ID: 26687013
[TBL] [Abstract][Full Text] [Related]
38. Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder.
Bishnoi R; Minish J; Franke AJ; Skelton WP; Shah CP; Wang Y; Dang NH
Cureus; 2020 Feb; 12(2):e6912. PubMed ID: 32190467
[TBL] [Abstract][Full Text] [Related]
39. PD-1 Blockade Aggravates Epstein-Barr Virus
Volk V; Theobald SJ; Danisch S; Khailaie S; Kalbarczyk M; Schneider A; Bialek-Waldmann J; Krönke N; Deng Y; Eiz-Vesper B; Dragon AC; von Kaisenberg C; Lienenklaus S; Bleich A; Keck J; Meyer-Hermann M; Klawonn F; Hammerschmidt W; Delecluse HJ; Münz C; Feuerhake F; Stripecke R
Front Oncol; 2020; 10():614876. PubMed ID: 33511078
[TBL] [Abstract][Full Text] [Related]
40. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Maloney DG
Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
